The actin targeting compound Chondramide inhibits breast cancer metastasis via reduction of cellular contractility.
| dc.contributor.author | Menhofer, Magdalena H | |
| dc.contributor.author | Kubisch, Rebekka | |
| dc.contributor.author | Schreiner, Laura | |
| dc.contributor.author | Zorn, Matthias | |
| dc.contributor.author | Foerster, Florian | |
| dc.contributor.author | Mueller, Rolf | |
| dc.contributor.author | Raedler, Joachim O | |
| dc.contributor.author | Wagner, Ernst | |
| dc.contributor.author | Vollmar, Angelika M | |
| dc.contributor.author | Zahler, Stefan | |
| dc.date.accessioned | 2015-04-13T12:56:41Z | en |
| dc.date.available | 2015-04-13T12:56:41Z | en |
| dc.date.issued | 2014 | en |
| dc.identifier.citation | The actin targeting compound Chondramide inhibits breast cancer metastasis via reduction of cellular contractility. 2014, 9 (11):e112542 PLoS ONE | en |
| dc.identifier.issn | 1932-6203 | en |
| dc.identifier.pmid | 25391145 | en |
| dc.identifier.doi | 10.1371/journal.pone.0112542 | en |
| dc.identifier.uri | http://hdl.handle.net/10033/528570 | en |
| dc.description.abstract | A major player in the process of metastasis is the actin cytoskeleton as it forms key structures in both invasion mechanisms, mesenchymal and amoeboid migration. We tested the actin binding compound Chondramide as potential anti-metastatic agent. | |
| dc.language.iso | en | en |
| dc.title | The actin targeting compound Chondramide inhibits breast cancer metastasis via reduction of cellular contractility. | en |
| dc.type | Article | en |
| dc.contributor.department | Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Saarland University, Saarbru ¨ cken, Germany. | en |
| dc.identifier.journal | PloS one | en |
| refterms.dateFOA | 2018-06-13T21:21:44Z | |
| html.description.abstract | A major player in the process of metastasis is the actin cytoskeleton as it forms key structures in both invasion mechanisms, mesenchymal and amoeboid migration. We tested the actin binding compound Chondramide as potential anti-metastatic agent. |
Files in this item
Name:
Menhofer et al_final.pdf
Size:
1.673Mb
Format:
PDF
Description:
Open Access publication
Name:
journal.pone.0112542.s001.tif
Size:
1.991Mb
Format:
TIFF image
Description:
supporting figure S1
Name:
journal.pone.0112542.s002.tif
Size:
6.208Mb
Format:
TIFF image
Description:
supporting figure S2
Name:
journal.pone.0112542.s003.tif
Size:
1.225Mb
Format:
TIFF image
Description:
supporting figure S3
